Related Experiment Videos
[Present status in the development of new antineoplastic agents]
1I. internk klinika 1, LF UK, Praha.
Casopis Lekaru Ceskych
|January 3, 1994
Summary
Despite a stagnation in new anti-tumour drugs, recent years have seen the introduction of novel cytostatics. Many are improved derivatives of existing drugs, aiming for enhanced efficacy and reduced toxicity in cancer treatment.
Area of Science:
- Oncology
- Pharmacology
Context:
- Chemotherapeutic agent development has faced stagnation since the late 1970s.
- Limited introduction of fundamentally new anti-tumour drugs into clinical practice.
Purpose:
- To summarize recent advancements in cytostatics.
- To review initial clinical experiences with new anti-cancer drugs.
Summary:
- The range of clinically used cytostatics has expanded with new drug introductions.
- Most novel cytostatics are derivatives of established drugs, modified to improve anti-tumour effects or decrease toxicity.
Impact:
- Provides an overview of emerging chemotherapeutic agents.
- Offers insights into the practical application and efficacy of new cytostatics in cancer therapy.